1. Home
  2. APC vs CSTL Comparison

APC vs CSTL Comparison

Compare APC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Petroleum Corp. Class A Common Stock

APC

ARKO Petroleum Corp. Class A Common Stock

N/A

Current Price

$20.30

Market Cap

884.3M

Sector

Energy

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$28.00

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APC
CSTL
Founded
2025
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.3M
722.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
APC
CSTL
Price
$20.30
$28.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$21.75
$45.50
AVG Volume (30 Days)
84.9K
290.0K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
10.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
$4.47
$2.42
Revenue Next Year
$4.20
$12.69
P/E Ratio
$25.80
N/A
Revenue Growth
N/A
3.66
52 Week Low
$17.08
$14.59
52 Week High
$21.72
$44.28

Technical Indicators

Market Signals
Indicator
APC
CSTL
Relative Strength Index (RSI) 50.74 75.45
Support Level $17.55 $22.67
Resistance Level $21.48 $34.97
Average True Range (ATR) 0.75 1.31
MACD -0.06 0.33
Stochastic Oscillator 20.78 84.88

Price Performance

Historical Comparison
APC
CSTL

About APC ARKO Petroleum Corp. Class A Common Stock

Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: